Condition

Narcolepsy Type 1

Treatments and trials tagged Narcolepsy Type 1, with the same country and access zoom as New Developments.

Narcolepsy Type 1 breakthroughs

All countries United States Canada United Kingdom Japan China Australia Switzerland European Union Newest Patient Stories

FDA ApprovedUnited States Canada

New Oral Medicine for Narcolepsy Type 1 in Adults

Orzeyful (oveporexton) for narcolepsy type 1

The FDA labelled oveporexton for adults with narcolepsy type 1 on 5 August 2026 — and said it will be lawful to market only after DEA scheduling. Japan’s PMDA…

The FDA labelled oveporexton for adults with narcolepsy type 1 on 5 August 2026 — and said it will be lawful…

September 7, 2026